Amgen Inc. Share Price and Company Fundamentals



Price
$250.83
Change
-1.470 (-0.583%)
52 week
207.33 - 276.69

Last traded: Last Wednesday at 8:00 PM

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; and Datos Health. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Key Metrics

PE ratio

20.78

PB ratio

15.46

Dividend yield

2.60%

Beta

0.74

Market cap

$144.12B

Enterprise value

$164.24B

Company profile

Industry / SectorDrug Manufacturers—General / Healthcare
Full time employees24300
Websitehttp://www.amgen.com
Mailing addressOne Amgen Center Drive Thousand Oaks CA 91320-1799 United States
Phone / Fax805 447 1000 / 805 447 1010

Dividends

Dividend yield

2.60%

Dividend amount

$6.56

Payout ratio

54.35%

5Y Avg. yield

2.64%

Amgen Inc. paid $6.56 dividend and the ex-dividend date was 13 May 2021.The dividend payout ratio is 54.35%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.AMGN dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

AMGN's forward dividend amount is $7.04 and the forward dividend yield is 2.85%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of May 2021, following are the company executives and directors listed on Amgen Inc..

NameTitleAgeTotal Pay
Mr. Robert A. BradwayChairman, CEO & Pres575.73M
Mr. Peter H. GriffithExec. VP & CFO612.57M
Mr. Esteban SantosExec. VP of Operations522.59M
Dr. David M. Reese M.D.Exec. VP of R&D572.71M
Mr. Murdo GordonExec. VP of Global Commercial Operations532.88M
Ms. Linda H. LouieVP of Fin. & Chief Accounting Officer
Mr. Mike ZahigianSr. VP & Chief Information Officer
Mr. Arvind SoodVP of Investor Relations
Mr. Jonathan P. GrahamExec. VP, Gen. Counsel & Sec.59
Ms. Nancy A. GrygielSr. VP of Worldwide Compliance & Bus. Ethics and Chief Compliance Officer52

Profitability and management effectiveness

Profit margin

28.16%

Operating margin

36.17%

Return on assets

9.16%

Return on equity

75.30%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Amgen Inc. is 144.12B and its enterprise value is 164.24B. The enterprise value to revenue ratio of AMGN is 6.53.

The AMGN's stocks Beta value is 0.74 making it 26% less volatile compared to NASDAQ market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Amgen Inc. (NASDAQ:AMGN) Frequently Asked Questions

1. What is Amgen Inc.'s Stock Symbol?

Amgen Inc. trades on NASDAQ under the ticker symbol "AMGN".

2. What is Amgen Inc.'s stock price today?

One share of AMGN stock can currently be purchased for approximately $250.83.

3. How can I contact Amgen Inc.?

Amgen Inc.'s mailing address is One Amgen Center Drive Thousand Oaks CA 91320-1799 United States. The company can be reached via phone at 805 447 1000.

4. What is Amgen Inc.'s official website?

The official website of Amgen Inc. is http://www.amgen.com.